Dmitriy Zamarin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 60 papers. Top paper: “Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study”.

Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0328

N/A

2.1DataRank · unranked

61 citations

Omid Hamid, Asha Nayak-Kapoor, Solmaz Sahebjam, Mario Sznol, Agron Collaku +4 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Ovarian cancer mutational processes drive site-specific immune evasion

Nature(2022)10.1038/s41586-022-05496-1

N/A

0.863DataRank · unranked

314 citations

Florian Uhlitz, Nicholas Ceglia, Jamie Lim, Michelle Wu, Neeman Mohibullah +56 more

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses

Nature Medicine(2024)10.1038/s41591-024-02942-7

N/A

0.790DataRank · unranked

26 citations

Beryl Manning‐Geist, Qin Zhou, Tara E. Soumerai, Aliya Holland, Arnaud Da Cruz Paula +23 more

Ovarian cancer-derived IL-4 promotes immunotherapy resistance

Cell(2024)10.1016/j.cell.2024.10.006

N/A

0.694DataRank · unranked

101 citations

Alexander Tepper, Chiara Falcomatà, Hunter Potak, Luisanna Pia, Angelo Amabile +14 more

Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2117754119

N/A

0.673DataRank · unranked

88 citations

Camilla Salvagno, Yu-Jui Ho, Matthew Limjoco, Timour Baslan, Sha Tian +9 more

Fundamental immune–oncogenicity trade-offs define driver mutation fitness

Nature(2022)10.1038/s41586-022-04696-z

N/A

0.663DataRank · unranked

82 citations

Roberta Zappasodi, Isabell Schulze, Zachary Sethna, Kelvin C. de Andrade, Dean F. Bajorin +25 more

Transgelin 2 guards T cell lipid metabolism and antitumour function

Nature(2024)10.1038/s41586-024-08071-y

N/A

0.633DataRank · unranked

67 citations

Deepika Awasthi, Jeong Jieun, Tito A. Sandoval, Chang-Suk Chae, Yusibeska Ramos +20 more

Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary

Nature Communications(2020)10.1038/s41467-019-13806-x

N/A

0.631DataRank · unranked

66 citations

Arnaud Da Cruz Paula, Thais Basili, Higinio Dopeso, Rui Bi, Fresia Pareja +23 more

Ongoing genome doubling shapes evolvability and immunity in ovarian cancer

Nature(2025)10.1038/s41586-025-09240-3

N/A

0.553DataRank · unranked

39 citations

Ignacio Vázquez-Garćıa, Matthew Myers, Duaa H. Al-Rawi, Matthew Zatzman, Adam C. Weiner +53 more

Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.015

N/A

0.533DataRank · unranked

34 citations

Deborah F. DeLair, Lorenzo Ferrando, Daniel Fix, Robert A. Soslow, Kay J. Park +16 more

Induction of a CD8 T cell intrinsic DNA damage and repair response is associated with clinical response to PD-1 blockade in uterine cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.16.488552

N/A

0.269DataRank · unranked

5 citations

Sasikanth Manne, Nils Wellhausen, Derek A. Oldridge, Allison R. Greenplate, Lakshmi Chilukuri +10 more

A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf089

N/A

0.269DataRank · unranked

5 citations

Dmitriy Zamarin, José R. Conejo-García, Kari Hacker, Roberto Vargas, Panagiotis A. Konstantinopoulos +6 more

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.06.021

N/A

0.241DataRank · unranked

4 citations

Austin Miller, Robert A. Soslow, Heather A. Lankes, Deborah F. DeLair, Sheila Segura +10 more

Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2023-004842

N/A

0.165DataRank · unranked

2 citations

Victoria Wan, Michael Finlan, Qin Zhou, Alexia Iasonos, Oliver Zivanovic +14 more

High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1134

N/A

0DataRank · unranked

73 citations

Pier Selenica, Juber Patel, Michelle Wu, Josip Ninčević, Yulia Lakhman +25 more

Microsatellite Instability–High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0713

N/A

0DataRank · unranked

67 citations

Ying L. Liu, Kelly A. Devereaux, Arnaud Da Cruz Paula, Qin Zhou, Weining Ma +18 more

Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1181

N/A

0DataRank · unranked

61 citations

Tito A. Sandoval, Sung‐Min Hwang, Eun Sil Park, Paolo Giovanelli, Deepika Awasthi +16 more

Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.003

N/A

0DataRank · unranked

48 citations

Dib Sassine, Alli Straubhar, Aaron Praiss, Carol Aghajanian, Kaled M. Alektiar +17 more

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.028

N/A

0DataRank · unranked

23 citations

Eric Rios Doria, Jason Konner, Stuart M. Lichtman, Qin Zhou, Alexia Iasonos +18 more

Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.02.022

N/A

0DataRank · unranked

15 citations

Lorenzo Ferrando, Higinio Dopeso, Anthe A. Stylianou, Thais Basili, Fresia Pareja +14 more

Recurrent WWTR1S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix

The Journal of Pathology(2022)10.1002/path.5910

N/A

0DataRank · unranked

10 citations

Thais Basili, Higinio Dopeso, Arnaud Da Cruz Paula, Rui Bi, Shirin Issa Bhaloo +23 more

State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report

JCO Precision Oncology(2022)10.1200/po.22.00355

N/A

0DataRank · unranked

8 citations

Katherine C. Fuh, Rebecca C. Arend, Gottfried E. Konecny, Panagiotis A. Konstantinopoulos, Kunle Odunsi +4 more

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1078

N/A

0DataRank · unranked

20 citations

Vignesh Ravichandran, Kathryn Miller, Chad Vanderbilt, Qin Zhou, Alexia Iasonos +17 more

Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission

Cancers(2023)10.3390/cancers15051458

N/A

0DataRank · unranked

20 citations

Sacha Gnjatic, Carol Aghajanian, Jason Konner, Sarah H. Kim, Debra Sarasohn +12 more

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.11.019

N/A

0DataRank · unranked

19 citations

Pier Selenica, Thomas Boerner, Kara Long Roche, Yonghong Xiao, Tiffany Sia +23 more

Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.01.037

N/A

0DataRank · unranked

17 citations

Lorenzo Ferrando, Qin Zhou, Alexia Iasonos, Nadeem R. Abu‐Rustum, Jorge S. Reis‐Filho +4 more

APR-246 increases tumor antigenicity independent of p53

Life Science Alliance(2023)10.26508/lsa.202301999

N/A

0DataRank · unranked

5 citations

Divya Venkatesh, Cailian Liu, Sadna Budhu, Hong Zhong, Mariam M. George +11 more

Shedding Light on PARP Inhibitor Response through Functional Imaging

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3711

N/A

0DataRank · unranked

2 citations

Dmitriy Zamarin, Ying L. Liu

Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer

Gynecologic Oncology Reports(2023)10.1016/j.gore.2023.101258

N/A

0DataRank · unranked

3 citations

Debra Sarasohn, Britta Weigelt, Dmitriy Zamarin, Clarissa Lam

Transgelin 2 guards T cell lipid metabolic programming and anti-tumor function

Research Square(2023)10.21203/rs.3.rs-3683989/v1

N/A

0DataRank · unranked

4 citations

Deepika Awasthi, Jeong Jieun, Tito A. Sandoval, Chang-Suk Chae, Yusibeska Ramos +17 more

Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer

Research Square(2023)10.21203/rs.3.rs-3399219/v1

N/A

0DataRank · unranked

1 citations

Chang-Suk Chae, Camilla Salvagno, Deepika Awasthi, Elí Terán-Cabanillas, Maria A. Sierra +25 more

Data from Microsatellite Instability–High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles

(2023)10.1158/1078-0432.c.6532995.v1

N/A

0DataRank · unranked

0 citations

Ying L. Liu, Kelly A. Devereaux, Arnaud Da Cruz Paula, Qin Zhou, Weining Ma +18 more

Data from Tumor Immunity and Immunotherapy for HPV-Related Cancers

(2023)10.1158/2159-8290.c.6549001.v1

N/A

0DataRank · unranked

0 citations

Bharat Burman, Nancy Y. Lee, Dmitriy Zamarin, Nadeem Riaz, A. Shamseddine

Data from Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer

(2023)10.1158/2159-8290.c.6549535

N/A

0DataRank · unranked

0 citations

Tito A. Sandoval, Sung‐Min Hwang, Eun Sil Park, Paolo Giovanelli, Deepika Awasthi +16 more

Germline variants in non-BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5565

N/A

0DataRank · unranked

0 citations

Pier Selenica, Thomas Boerner, Yonghong Xiao, Tiffany Sia, Margaret Sheehan +15 more

Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-23-1451

N/A

0DataRank · unranked

24 citations

Camilla Salvagno, Chang-Suk Chae, Deepika Awasthi, Paolo Giovanelli, Matías Marín Falco +27 more

Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005522

N/A

0DataRank · unranked

9 citations

Nadeem R. Abu‐Rustum, Kaled M. Alektiar, Vicky Makker, Ying L. Liu, Dmitriy Zamarin +8 more

2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005567

N/A

0DataRank · unranked

2 citations

Nadeem R. Abu‐Rustum, Gretchen Glaser, Michaela McGree, Ane Gerda Zahl Eriksson, Melissa Pham +7 more

Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulva

International Journal of Gynecological Cancer(2024)10.1016/j.ijgc.2024.100051

N/A

0DataRank · unranked

2 citations

Olga T. Filippova, Arnaud Da Cruz Paula, Juan Blanco-Heredia, Hunter Green, Vance Broach +7 more

Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.07.11.602772

N/A

0DataRank · unranked

11 citations

Ignacio Vázquez-Garćıa, Matthew Myers, Matthew Zatzman, Duaa H. Al-Rawi, Adam C. Weiner +52 more

Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.08.21.609031

N/A

0DataRank · unranked

7 citations

Ignacio Vázquez-Garćıa, Grittney Tam, Michelle Wu, Nancy Varice, Eliyahu Havasov +22 more

Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial

Nature Communications(2025)10.1038/s41467-024-55200-2

N/A

0DataRank · unranked

18 citations

Dmitriy Zamarin, Wei Deng, Heather A. Lankes, Giulio Pesci, Hayeon Kim +19 more

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer

Brachytherapy(2025)10.1016/j.brachy.2025.09.011

N/A

0DataRank · unranked

2 citations

Wei Deng, Dmitriy Zamarin, Ying Xiao, Junzo Chino, Stanley Benedict +18 more

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

Nature Communications(2020)10.1038/s41467-020-17750-z

N/A

0DataRank · unranked

480 citations

Sadna Budhu, Jeremy H. Tchaicha, Chien‐Huan Weng, Mathieu Gigoux, Ivan Cohen +13 more

Evolution of tumor stress response during cytoreductive surgery for ovarian cancer

iScience(2025)10.1016/j.isci.2025.112317

N/A

0DataRank · unranked

1 citations

Lea A. Moukarzel, Yingjie Zhu, Ana Leda F. Longhini, Fatemeh Derakhshan, Timothy Hoang +18 more

Newcastle Disease Virus at the Forefront of Cancer Immunotherapy

Cancers(2020)10.3390/cancers12123552

N/A

0DataRank · unranked

94 citations

Giulio Pesci, Dmitriy Zamarin, Bharat Burman

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.10.019

N/A

0DataRank · unranked

16 citations

Rachel N. Grisham, Karen A. Cadoo, Chrisann Kyi, William P. Tew, Claire F. Friedman +14 more

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

Cell(2021)10.1016/j.cell.2021.05.038

N/A

0DataRank · unranked

284 citations

Emma De Neef, James D. Thomas, Erich Sabio, Benoı̂t Rousseau, Mathieu Gigoux +30 more

Tumor Immunity and Immunotherapy for HPV-Related Cancers

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1760

N/A

0DataRank · unranked

198 citations

Bharat Burman, Nancy Y. Lee, Dmitriy Zamarin, Nadeem Riaz, Achraf A. Shamseddine

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies

Scientific Reports(2021)10.1038/s41598-021-82686-3

N/A

0DataRank · unranked

34 citations

Evan Smith, Oladapo Yeku, Kay J. Park, Ian Laster, Kwangkook Lee +8 more

Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors

npj Genomic Medicine(2021)10.1038/s41525-021-00259-9

N/A

0DataRank · unranked

28 citations

Jung Hun Oh, Ying L. Liu, Pier Selenica, Britta Weigelt, Jorge S. Reis‐Filho +6 more

Targeting Ribonucleotide Reductase Induces Synthetic Lethality in PP2A-Deficient Uterine Serous Carcinoma

Cancer Research(2021)10.1158/0008-5472.can-21-1987

N/A

0DataRank · unranked

13 citations

Sarah E. Taylor, Kathryn Miller, Lauren Hurst, Terrance J. Haanen, Tahra K. Suhan +9 more

Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.10.087

N/A

0DataRank · unranked

12 citations

Sushmita Gordhandas, Dilip D. Giri, Alexia Iasonos, Qin Zhou, Jeffrey Girshman +12 more

Pattern of disease and response to pembrolizumab in recurrent cervical cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100831

N/A

0DataRank · unranked

9 citations

Olga T. Filippova, Sara A. Hayes, Nadeem R. Abu‐Rustum, Carol Aghajanian, Vance Broach +14 more

Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.028

N/A

0DataRank · unranked

13 citations

Pier Selenica, Fresia Pareja, Mahsa Vahdatinia, Yingjie Zhu, Xin Pei +9 more

The impact of mutational processes on structural genomic plasticity in cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.03.446999

N/A

0DataRank · unranked

5 citations

Ciara H. O’Flanagan, Marc Williams, Andrew McPherson, Steven McKinney, Farhia Kabeer +38 more

Geometric Network Analysis Provides Prognostic Information in Patients with High Grade Serous Carcinoma of the Ovary Treated with Immune Checkpoint Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.10.447889

N/A

0DataRank · unranked

2 citations

Jung Hun Oh, Ying L. Liu, Pier Selenica, Britta Weigelt, Jorge S. Reis‐Filho +6 more

Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer

Nature Cancer(2022)10.1038/s43018-022-00388-9

N/A

0DataRank · unranked

347 citations

Emily A. Aherne, Lora H. Ellenson, Ines Nikolovski, Mohammed Alghamdi, Ignacio Vázquez-Garćıa +22 more

Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity

Nature Genetics(2022)10.1038/s41588-022-01108-w

N/A

0DataRank · unranked

79 citations

Nadeem Riaz, Robert Samstein, Mark Lee, Vladimir Makarov, Cristina Valero +29 more